Biodynamic Hematogel Wound Care in Port St. Lucie, FL

Port St. Lucie epidemiology first — then the SKU

14.5% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 13.1% of adults in Port St. Lucie have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Population 204,851. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JN documentation are ready before the first application of biodynamic hematogel.

The chart problems we still see in FL

• CDC PLACES (2023, crude) estimates 13.1% of adults in Port St. Lucie have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Adult obesity in Port St. Lucie is 30.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails JN review. Product is the last step, not the first.
• Joint-preservation biologics compete with cortisone and viscosupplementation pathways that already have familiar CPT habits. The operational gap in Florida is staff training and consent language, not another brand name on a centrifuge.
• FDA does not “approve” 361 HCT/Ps the way it clears a 510(k) device. Clinics in Florida should not advertise allografts as FDA-approved stem cell therapy. That sentence is how investigations start.

Why we will not invent a Port St. Lucie diabetes rate

Three grains, kept separate on purpose. City: Census 204,851 and CDC PLACES crude rates. State: Florida Department of Health, Diabetes Belt counties present. Federal: 21 CFR 1271 and First Coast Service Options LCDs. CDC PLACES (2023, crude) estimates 13.1% of adults in Port St. Lucie have diagnosed diabetes — 1.1 points above the U.S. 12% figure.

Do this before you expand SKUs